Health iQ Launches an Innovative New Storytelling Module to Its Real-World Data Platform

Health iQ new products (PRNewsfoto/Corrona, LLC)
WALTHAM, Mass. and LONDON, April 20, 2021 /PRNewswire/ -- Real-world evidence provider Health iQ has launched a new module to add to its collection of cutting-edge healthcare analytics solutions.

Powered by Vantage, the Storyboard module combines the most complete disease, treatment and procedure level data available to present a multi-dimensional view of the healthcare landscape. And by utilising the latest technology, it translates this complex data into visualisations that effortlessly communicate a unique value story.

The user-friendly interface quickly enables teams to identify and create the valuable real-world insights required to support the case for change. In addition, the module has export functionality, so a story can be easily shared online, offline, remotely or face-to-face.

More on Boston Chron
Chief Product Officer Yasir Hassan cited, "Pharma and healthcare have a powerful shared narrative of supporting the patient. Storyboard allows us to use RWE to tell that story in a new and unique way."

"Our new Storyboard module cuts through the data to present ideas in a highly visual, digestible and memorable way. This enables organisations to present a robust, reliable and relatable story that engages stakeholders and supports the case for change," noted Jilani Gulam, CEO of Health iQ.

For more information on Storyboard, visit

For more information, please contact:
Cara Wickersham
Health iQ
07939 085483
[email protected]

More on Boston Chron
About Health iQ and CorEvitasSM

Health iQ, a division of CorEvitas LLC, is a healthcare and life sciences consultancy. Utilising pioneering technology, real-world data is transformed into actionable insight that solves complex healthcare challenges. For more information visit

CorEvitas is the built-for-purpose gold-standard provider of real-world evidence.  Through syndicated registry data and analytic services, CorEvitas helps biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators. CorEvitas is a portfolio company of Audax Private Equity.

SOURCE CorEvitas
Filed Under: Business

Show All News | Report Violation


Latest on Boston Chron